Journal of Enzyme Inhibition and Medicinal Chemistry (Jan 2018)

Synthesis and characterisation of (Z)-styrylbenzene derivatives as potential selective anticancer agents

  • Ya-Bing Xin,
  • Jia-Jun Li,
  • Hong-Jian Zhang,
  • Jun Ma,
  • Xin Liu,
  • Guo-Hua Gong,
  • Yu-Shun Tian

DOI
https://doi.org/10.1080/14756366.2018.1513925
Journal volume & issue
Vol. 33, no. 1
pp. 1554 – 1564

Abstract

Read online

To identify anticancer agents with high potency and low toxicity, a series of (Z)-styrylbenzene derivatives were synthesised and evaluated for anticancer activities using a panel of nine cancer cell lines and two noncancerous cell lines. Most derivatives exhibited significant anti-proliferative activities against five cancer cell lines, including MGC-803 and BEL-7402. (Z)-3-(p-Tolyl)-2-(3,4,5-trimethoxyphenyl)acrylonitrile (6h) showed a strong inhibitory effect on MGC-803 cells (IC50 < 0.01 µM) and exhibited stronger anti-proliferative activity than taxol (IC50 < 0.06 ± 0.01 µM). The IC50 value of 6h in L-02 cells was 10,000-fold higher than in MGC-803 cells. Compound 6h inhibited proliferation of BEL-7402 cells by arresting at the G2/M phase through up-regulation of cyclin B1 expression, down-regulation of cyclin A and D1 expression, and induction of apoptosis. In addition, 6h inhibited the migration of BEL-7402 cells and the formation of cell colonies.

Keywords